The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Abingworth Management Ltd since year 2005.
The trader's CIK number is 1291892.
At the time of this reporting, Abingworth Management Ltd is the 10% Owner of Supernus Pharmaceuticals Inc .
(stock ticker symbol SUPN).
See this page for all insider trading activities at Supernus Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2012-05-04||SUPN||Supernus Pharmaceuticals Inc||Buy||1,100,000||5.00||5,500,000|
|2004-05-27||ALNY||Alnylam Pharmaceuticals, Inc.||Buy||130,520||6.00||783,120|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Abingworth Management Ltd (10% Owner of Supernus Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.